The Board of Directors of Zhejiang Hisun Pharmaceutical Co., Ltd. has authorized a buyback plan on December 22, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.26 CNY | -0.96% | -2.48% | -11.75% |
May. 20 | Hisun Pharma's Veterinary Arm Gets Approval to Register Amoxicillin and Clavulanate Potassium Dry Suspension | MT |
May. 16 | Hisun Pharma's Veterinary Arm Gets Nod to Market Selamectin Drops | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.75% | 1.36B | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- 600267 Stock
- News Zhejiang Hisun Pharmaceutical Co., Ltd.
- Zhejiang Hisun Pharmaceutical Co., Ltd. authorizes a Buyback Plan.